Technical Analysis for TMDX - TransMedics Group, Inc.

Grade Last Price % Change Price Change
grade D 18.21 1.73% 0.31
TMDX closed up 1.73 percent on Thursday, October 17, 2019, on 1.13 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Earnings due: Nov 7

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Up
See historical TMDX trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 1.73%
Wide Bands Range Expansion 1.73%
Oversold Stochastic Weakness 1.73%
Narrow Range Bar Range Contraction 2.25%
Stochastic Reached Oversold Weakness 2.25%
Inside Day Range Contraction 2.25%

Older signals for TMDX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
TransMedics, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The company offers Organ Care System (OCS), an integrated, compact, portable preservation technology that addresses unmet need for organs for transplantation. Its Organ Care System preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Its Organ Care System incudes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains organs in a near physiologic state and enables surgeons to perfuse and ventilate the organ between the donor and recipient sites; OCS Heart, a portable heart perfusion system that helps to maintain organs in a warm functioning state outside of the body; and OCS Liver, a portable perfusion and monitoring system that maintains organs in a near physiologic state. The company offers its products in the United States and internationally. TransMedics, Inc. is headquartered in Andover, Massachusetts. TransMedics, Inc. is a subsidiary of Transmedics Group, Inc.
Medicine Medical Specialties Disease Surgery Medical Technology Transplantation Organ Transplantation Transplantation Medicine Organ Transplant
Is TMDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 31.54
52 Week Low 16.92
Average Volume 69,318
200-Day Moving Average 0.0
50-Day Moving Average 21.9398
20-Day Moving Average 20.3845
10-Day Moving Average 17.963
Average True Range 1.3351
ADX 28.52
+DI 16.9888
-DI 27.9741
Chandelier Exit (Long, 3 ATRs ) 21.2947
Chandelier Exit (Short, 3 ATRs ) 20.9253
Upper Bollinger Band 25.9816
Lower Bollinger Band 14.7874
Percent B (%b) 0.31
BandWidth 54.915254
MACD Line -1.5099
MACD Signal Line -1.3712
MACD Histogram -0.1387
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.55
Resistance 3 (R3) 19.43 18.87 19.32
Resistance 2 (R2) 18.87 18.53 18.93 19.25
Resistance 1 (R1) 18.54 18.32 18.71 18.66 19.17
Pivot Point 17.98 17.98 18.06 18.04 17.98
Support 1 (S1) 17.65 17.64 17.82 17.77 17.25
Support 2 (S2) 17.09 17.43 17.15 17.17
Support 3 (S3) 16.76 17.09 17.10
Support 4 (S4) 16.88